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Background: Derangements in skeletal muscle (SM) metabolism and function develop in heart failure (HF). SM metabolism switches to 
preferential utilization of glycolytic substrates reflected by an increased number of fast-twitch SM fibers. Further, insulin resistance and loss of 
muscle mass contribute to exercise intolerance in HF. We analyzed metabolic gene expression patterns and fiber cross-sectional area (CSA) in 
skeletal muscle in order to characterize abnormalities of metabolism and atrophy in HF.
Methods: Ligation of the left coronary artery (MI) or sham surgery was performed in C57BL/6 mice (8 wks, n=5 per group). After 8 wks, 
echocardiography was performed and the extensor digitorum longus (EDL), soleus (SOL) and quadriceps (QUA) muscles were isolated. Gene 
expression was assessed by qRT-PCR. Muscle fiber CSA was analyzed using ImageJ.
Results: Echocardiography confirmed impaired cardiac function post-MI (fractional shortening: 23.7+/-1.9% in MI vs 31.5+/-0.8% in sham, 
p<0.005). No differences were found in total body weight (BW) while heart weight/BW increased in the MI group. SM weight/BW was reduced in 
the MI group (p<0.05 vs sham). GLUT4 mRNA was increased with concurrent decrease in PDK4 mRNA indicating an increase in glucose oxidation. 
Markers of lipid uptake and oxidation (PPARg, CPT1, CD36) remained unchanged. Notably, PGC-1a, a critical regulator of oxidative metabolism, 
showed a trend towards decreased expression in the MI group. Expression of the lipolytic enzyme ATGL decreased in EDL and QUA. Muscle CSA was 
decreased in EDL and QUA (EDL: 1237+/-480 um2 vs 1587+/-494 um2 in sham, p<0.001, SOL: 1230+/-384 um2 vs 1240+/-356 um2 in sham, 
p=NS, QUA: 1542+/-484 um2 vs 1713+/-552 um2 in sham, p<0.001).
Conclusion: Our data demonstrate a distinct metabolic gene expression pattern with a shift towards increased glucose transport and oxidation 
with stable lipid uptake and oxidation in SM of animals with left ventricular dysfunction. Our findings are consistent with preferential utilization of 
glucose for ATP generation. We hypothesize that abnormal substrate utilization in SM contributes to the development and progression of catabolic 
metabolism and muscle atrophy in HF.
